
1. bioorg med chem lett. 2004 dec 6;14(23):5925-9.

identification peptidomimetic htlv-i protease inhibitors containing
hydroxymethylcarbonyl (hmc) isostere transition-state mimic.

maegawa h(1), kimura t, arii y, matsui y, kasai s, hayashi y, kiso y.

author information: 
(1)department medicinal chemistry, center frontier research medicinal
science, kyoto pharmaceutical university, yamashina-ku, kyoto 607-8412, japan.

towards development chemotherapy infection human t-cell
leukemia virus type (htlv-i), established evaluation systems htlv-i
protease (pr) inhibitors using recombinant chemically synthesized htlv-i
prs. newly synthesized substrate-based inhibitors containing
hydroxymethylcarbonyl (hmc) isostere showed potent anti-htlv-i pr activity.

doi: 10.1016/j.bmcl.2004.09.034 
pmid: 15501070  [indexed medline]

